Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
FITC-Dextran 70 (AC173)
Cat.#: ASSD-173
Specifications
Description FITC I dextran is dextran labeled with fluorescein isothiocyanate for possible use to study the capacity, selectivity, and efficiency of encapsulation and release by drug delivery vehicles. Synonyms FITC-Dextran 70 is also known as Fluorescein isothiocyanate–dextran. Size 100 mg, 500 mg Applications Dextran labeled with fluorescein isothiocyanate. Used for possible use in live animals imaging. Molecule Weight ~70,000 CAS Number 60842-46-8 MDL Number MFCD00131092 Solubility Soluble in water (50 mg/mL--hazy, orange to very deep orange). Excitation 492 nm Emission 512 nm Storage Desiccate at 4° C Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ASSD-196 5-Carboxyfluorescein (AC196) 100 mg, 250 mg inquiry ASSD-129 Fluorescent 5-HT1A antagonist [NAN-190] (AC129) 50 μg inquiry ASSD-150 Luminol (AC150) 1 g inquiry ASSD-187 Quinaldine Red (AC187) 5 g, 25 g, 100 g, 250 g inquiry ASSD-191 Fluorescein 6-Isothiocyanate, Isomer 2, 95% (AC191) 100 mg inquiry ASSD-145 Oxazole Yellow Iodide 1mM solution (in 1mL DMSO) (AC145) 1 mL inquiry ASSD-210 7-Amino-4-methyl-3-coumarinacetic acid N-succinimidyl ester (AC210) 5 mg inquiry ASSD-125 Fluorescent D1 antagonist [SKF83566-green] (AC125) 50 μg inquiry ASSD-143 Fluorescently labeled Muscimol TMR-X conjugate (AC143) 1mg inquiry ASSD-134 FITC Phalloidin (AC134) 300 tests, 100μg inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket